Topical Corticosteroid Boxed Warning On Immunosuppression Urged By Cmte.
Executive Summary
A topical corticosteroid boxed warning on the risk of hypothalamic pituitary adrenal axis suppression in pediatric patients may be an appropriate risk management tactic, an FDA advisory committee said
You may also be interested in...
CDER Guidance Agenda 2004: Pregnancy, Pediatric Studies Are Priorities
FDA is planning several new guidances to refine recommendations for drug studies in children and pregnant women during 2004, the Center for Drug Evaluation & Research's guidance agenda for the coming year indicates
CDER Guidance Agenda 2004: Pregnancy, Pediatric Studies Are Priorities
FDA is planning several new guidances to refine recommendations for drug studies in children and pregnant women during 2004, the Center for Drug Evaluation & Research's guidance agenda for the coming year indicates
Protopic, Elidel Safety Labeling May Be Reviewed, FDA Tells Pediatric Cmte.
FDA plans to discuss the pediatric safety profile of topical immunosuppressants with Novartis and Fujisawa after an advisory committee recommended stronger warnings about the potential carcinogenicity of Elidel and Protopic